Thoracic endovascular aortic repair in 58 patients with Stanford type B aortic dissection
10.3760/cma.j.issn.1673-4904.2015.01.011
- VernacularTitle:胸主动脉腔内修复术治疗58例Stanford B型主动脉夹层
- Author:
Jun LU
;
Jun XIN
;
Wei ZHOU
;
Weiyang LI
- Publication Type:Journal Article
- Keywords:
Stents;
Aortic dissection,Stanford type B;
Thoracic endovascular aortic repair
- From:
Chinese Journal of Postgraduates of Medicine
2015;38(1):32-34
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the efficacy and clinical resuhs of thoracic endovascular aortic repair (TEVAR) in Stanford type B aortic dissection,and to explore the therapentic strategy and prevention of complication.Methods Fifty-eight patients with Stanford type B aortic dissection underwent TEVAR were enrolled,and were followed up regularly.Results The technical feasibility and success with deployment proximal to the entry tear was 100.0％(58/58),requiring partial coverage of the left subclavian artery in 20 patients and total coverage in 4 patients,and 2 patients used chimney stents.Hospital mortality was 5.2％ (3/58).Type Ⅰ endoleak was found in 11 patients (19.0％,11/58).In 55 survival patients,48 patients occurred thrombosis in pseudocoele and 2 patients' endoleak disappeared.Seven patients' endoleak appeared blood flow.Forty-eight patients(87.3 ％,48/55) were followed up for 3-68 months.Two patients died,and 2 patients' endoleak disappeared,with total suberization in pseudocoele.Other 5 patients' endoleak relieved,with partial suberization in pseudocoele.One patient had new intimal tear at the distal end of the stent-graft and required a second stent implantation.Conclusion TEVAR is safe and effective for the treatment of Stanford type B aortic dissection.
